The challenges of psychopharmacological management of children with severe developmental disabilities

J Child Adolesc Psychopharmacol. 2006 Dec;16(6):793-9. doi: 10.1089/cap.2006.16.793.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Anticonvulsants / administration & dosage
  • Anticonvulsants / therapeutic use
  • Antipsychotic Agents / therapeutic use
  • Autistic Disorder / complications
  • Autistic Disorder / drug therapy
  • Caregivers
  • Child
  • Developmental Disabilities / drug therapy*
  • Epilepsy / complications
  • Epilepsy / drug therapy
  • Female
  • Foster Home Care
  • Fructose / analogs & derivatives
  • Fructose / therapeutic use
  • Humans
  • Impulsive Behavior / drug therapy
  • Mental Status Schedule
  • Psychological Tests
  • Risperidone / therapeutic use
  • Status Epilepticus / drug therapy
  • Topiramate
  • Valproic Acid / administration & dosage
  • Valproic Acid / therapeutic use

Substances

  • Anticonvulsants
  • Antipsychotic Agents
  • Topiramate
  • Fructose
  • Valproic Acid
  • Risperidone